NCT07170436

Brief Summary

This research project focuses on low-level cognitive functions such as perception (auditory, visual, etc.) and high-level cognitive functions (memory, language, temporal estimation, etc.). It aims to better understand the brain bases of these functions as well as their overlap (i.e., brain bases considered to be involved in different functions). To this end, various cognitive tasks will be performed before and during awake brain surgery, allowing us to determine the involvement of different areas in the task being performed. Comparing performance between the pre-test and the intraoperative test will help determine the potential involvement of the tested area.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
55mo left

Started Nov 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Nov 2025Nov 2030

First Submitted

Initial submission to the registry

September 3, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 12, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2025

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2030

Expected
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 8, 2030

Last Updated

September 12, 2025

Status Verified

September 1, 2025

Enrollment Period

5 years

First QC Date

September 3, 2025

Last Update Submit

September 11, 2025

Conditions

Keywords

surgeryawake surgerybrainbrain tumorbrain area

Outcome Measures

Primary Outcomes (1)

  • development of an atlas mapping the brain regions involved in each major cognitive function

    Analysis of the percentage of "yes" responses during the intraoperative phase, taking into account the expected probability based on preoperative results. Preoperative performance data allows to determine an expected performance level during the intraoperative phase.

    One day after the inclusion

Secondary Outcomes (2)

  • Number of tests

    One day after the inclusion

  • Location of brain tumors

    one day after the inclusion

Study Arms (2)

Pré-End

NO INTERVENTION

The day before surgery, brain tumor patients will be offered long-form cognitive tests. If the results of the cognitive tests are not consistent with the literature, this suggests that the tumor is affecting pre-contact time perception. These patients will not be tested during surgery.

Pré-Per

EXPERIMENTAL

The day before surgery, brain tumor patients will be offered long-form cognitive tests. If the results of the cognitive tests are consistent with the literature, the short-form cognitive tests will be offered during awake surgery.

Behavioral: Short version of cognitive testing during surgery

Interventions

Cognitive testing in 3 blocks of 3 minutes during awake surgery

Pré-Per

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a brain tumor
  • Aged 18 to 75 years
  • Signed informed consent
  • Vision that is corrected or adequate for the purposes of an experiment with visual stimuli
  • Hearing that is corrected or adequate for the purposes of an experiment with auditory stimuli
  • No known oculomotor disorder
  • Person affiliated with or benefiting from a social security scheme.

You may not qualify if:

  • Participants under protected status: guardianship, legal safeguard proceedings, or whose consent to participate in the experiment could be due to a severely altered psychological state, as determined by the medical team responsible for the surgery.
  • History of neurological disease affecting the central nervous system (Parkinson's, Alzheimer's, history of stroke or cerebral infarction)
  • Pregnant and/or breastfeeding women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Neurochirurgie, Hôpital Pierre Paul Riquet, Place du Docteur Baylac

Toulouse, Oui, 31300, France

Location

MeSH Terms

Conditions

Brain Neoplasms

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Franck Emmanuel ROUX, PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2025

First Posted

September 12, 2025

Study Start

November 1, 2025

Primary Completion (Estimated)

November 1, 2030

Study Completion (Estimated)

November 8, 2030

Last Updated

September 12, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations